- Investing Ideas
- Swedish Pharmaceuticals & Biotech Healthy potentially undervalued
Swedish Pharmaceuticals & Biotech Healthy potentially undervalued
Results
4
Companies which are potentially undervalued and in an acceptable financial position.
4 companies
Camurus
Market Cap: SEK 32.7b
A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.
CAMX
SEK 547.50
7D
4.0%
1Y
-14.3%
Swedish Orphan Biovitrum
Market Cap: SEK 154.5b
A biopharma company, provides medicines in the areas of haematology, immunology, and specialty care in Europe, North America, the Middle East, Asia, and Australia.
SOBI
SEK 446.60
7D
1.0%
1Y
45.4%
Bonesupport Holding
Market Cap: SEK 14.9b
An orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in the United States, Europe, and internationally.
BONEX
SEK 226.20
7D
-1.6%
1Y
-15.7%
Vitrolife
Market Cap: SEK 13.0b
Provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas.
VITR
SEK 96.15
7D
-2.8%
1Y
-38.9%